# Hyundai Bioscience: "Able to Supply Antiviral Drug in Event of Ebola or Hantavirus Spread"

- Link: https://www.thailand-business-news.com/pr-news/hyundai-bioscience-able-to-supply-antiviral-drug-in-event-of-ebola-or-hantavirus-spread
- Published: 2026-05-20T12:57:00+07:00
- Author: PR Newswire

|   |

SEOUL, South Korea, May 20, 2026 /PRNewswire/ — Hyundai Bioscience announced on 
May 19th that it can supply clinical trial doses of its broad-spectrum antiviral
drug XAFTY^(®) in response to growing global concern over infectious disease outbreaks
caused by Ebola and hantavirus.

Hyundai Bioscience said that if the World Health Organization (WHO) or countries
affected by infectious disease outbreaks request support for XAFTY^(®), it can immediately
provide products currently in stock.

According to the company, niclosamide, the main ingredient of XAFTY^(®), has previously
been reported to have inhibitory effects against Ebola and hantavirus.

The company stated, "In the ongoing Phase 2 clinical trial of XAFTY^(® )for dengue
fever in Vietnam, no adverse events have been reported so far," and claimed that"
in a situation where two viruses are spreading simultaneously, XAFTY^(® )could serve
as an effective alternative."

Hyundai Bioscience added that, as a member of the Medical CBRN Defense Consortium(
MCDC), a U.S. Department of Defense-supported consortium, it will actively cooperate
in responding to international public health crises.

CONTACT：
Jason Kim[gbd@hyundaibio.com](https://www.thailand-business-news.com/pr-news/gbd@hyundaibio.com)(
562) 964-3910

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Hyundai Bioscience: "Able to Supply Antiviral Drug in Event of Ebola or Hantavirus Spread" ](http://www.prnasia.com/story/archive/4963889_CN63889_0?rand=184833)
